Similar articles

• Problems associated with the clinical use of proton pump inhibitors.

  Gillen D, McColl KE. Gillen D, et al. Pharmacol Toxicol. 2001 Dec;89(6):281-6. doi: 10.1034/j.1600-0773.2001.d01-161.x. Pharmacol Toxicol. 2001. PMID: 11903952 Review.
• Marked increase in gastric acid secretory capacity after omeprazole treatment.

  Waldum HL, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Waldum HL, et al. Gut. 1996 Nov;39(5):649-53. doi: 10.1136/gut.39.5.649. Gut. 1996. PMID: 9026477 Free PMC article. Clinical Trial.
• Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion.

  Kuipers EJ, Klinkenberg-Knol EC. Kuipers EJ, et al. Gastroenterology. 1999 Feb;116(2):479-83. doi: 10.1016/s0016-5085(99)70145-9. Gastroenterology. 1999. PMID: 9922329 Review. No abstract available.
• Early epigastric pain after PPI administration: exacerbation of Helicobacter pylori corpus gastritis?

  Di Mario F, Ingegnoli A, Dal Bò N, Cavestro GM, Moussa AM, Cavallaro LG, Aragona G, Iori V, Pilotto A, Franzè A, Rugge M. Di Mario F, et al. Helicobacter. 2004 Feb;9(1):92-4. doi: 10.1111/j.1083-4389.2004.00203.x. Helicobacter. 2004. PMID: 15156910 No abstract available.
• Proton pump inhibitors and iron deficiency: is the connection real?

  Nand S, Tanvetyanon T. Nand S, et al. South Med J. 2004 Sep;97(9):799. doi: 10.1097/01.SMJ.0000118131.64942.F1. South Med J. 2004. PMID: 15455957 No abstract available.